Funds · compare two funds
Are these two funds really different?
Pick two funds to see how much of their Indian equity is the same: the companies both hold, and what each holds that the other does not.
Data periodFund holdingsEach fund’s latest monthly disclosureNSE prices23 Oct 2026Data status →
PGIM INDIA HEALTHCARE FUND vs Baroda BNP Paribas Health and Wellness Fund
Overlap adds up, for every company both funds hold, the smaller of its two shares of each fund’s disclosed Indian equity: identical portfolios overlap 100%, funds with nothing in common 0%. A figure describes how alike the portfolios are; it is not a judgement of either fund. Method →
See both funds combined in the Portfolio X-ray →
Top shared holdings
16 companies both funds hold · largest common part first
| Company | Sector | In A | In B | Common part |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | 10.80% | 8.84% | 8.84% |
| Torrent Pharmaceuticals Limited | Healthcare | 8.95% | 8.12% | 8.12% |
| Divi's Laboratories Limited | Healthcare | 10.92% | 8.05% | 8.05% |
| Dr. Lal Path Labs Ltd. | Healthcare | 4.56% | 3.57% | 3.57% |
| Mankind Pharma Limited | Healthcare | 4.26% | 3.44% | 3.44% |
| Abbott India Limited | Healthcare | 3.29% | 2.58% | 2.58% |
| Aster DM Quality Care Limited | Healthcare | 2.70% | 2.21% | 2.21% |
| Zydus Lifesciences Limited | Healthcare | 2.15% | 2.31% | 2.15% |
| Lupin Limited | Healthcare | 2.04% | 5.96% | 2.04% |
| IPCA Laboratories Limited | Healthcare | 2.02% | 6.31% | 2.02% |
| Ajanta Pharma Limited | Healthcare | 5.23% | 1.61% | 1.61% |
| Fortis Healthcare Limited | Healthcare | 1.53% | 4.10% | 1.53% |
| Manipal Health Enterprises Limited | Not classified | 3.87% | 1.27% | 1.27% |
| Gland Pharma Limited | Healthcare | 1.58% | 1.23% | 1.23% |
| Symbiotec Pharmalab Limited | Not classified | 1.16% | 1.51% | 1.16% |
| Cipla Limited | Healthcare | 2.15% | 1.14% | 1.14% |
Only in A
15 companies · largest first
- Max Healthcare Institute Limited4.97%
- Navin Fluorine International Limited3.42%
- Krishna Institute of Medical Sciences Limited3.15%
- Rubicon Research Limited3.15%
- Neuland Laboratories Limited3.06%
- Sai Life Sciences Limited2.68%
- ICICI Lombard General Insurance Company Limited2.21%
- Dr Agarwals Eye Hospital Limited1.96%
- Anthem Biosciences Limited1.91%
- Global Health Limited1.61%
- Jupiter Life Line Hospitals Limited1.54%
- Lenskart Solutions Limited1.04%
- Molbio Diagnostics Limited0.84%
- Orchid Pharma Limited0.83%
- SAGILITY LIMITED0.42%
Only in B
17 companies · largest first
- Laurus Labs Limited6.28%
- Apollo Hospitals Enterprise Limited5.44%
- Glenmark Pharmaceuticals Limited3.21%
- Aurobindo Pharma Limited3.18%
- AstraZeneca Pharma India Limited2.88%
- Emcure Pharmaceuticals Limited2.46%
- Acutaas Chemicals Limited2.43%
- Max Financial Services Limited2.28%
- Concord Biotech Limited2.18%
- Nephrocare Health Services Limited1.46%
- Metropolis Healthcare Limited1.37%
- Dr. Reddy's Laboratories Limited1.30%
- Narayana Hrudayalaya Ltd.1.00%
- Inventurus Knowledge Solutions Limited0.92%
- GlaxoSmithKline Pharmaceuticals Limited0.70%
And 2 more.
Sector mix side by side
Share of each fund’s disclosed equity
| Sector | A | B | Difference |
|---|---|---|---|
| Healthcare | 82.7% | 90.7% | -7.96 pp |
| Chemicals | 3.4% | 0.0% | +3.42 pp |
| Financial Services | 2.2% | 2.8% | -0.55 pp |
| Consumer Services | 1.0% | 0.0% | +1.04 pp |
| Information Technology | 0.4% | 0.9% | -0.50 pp |
| Not classified | 10.2% | 5.7% | +4.55 pp |
Built from each fund’s latest monthly disclosure of Indian listed shares, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not part of the comparison. Not a recommendation. Method →